AU Stock MarketDetailed Quotes
ACWOC Actinogen Medical Ltd
- 0.010
- +0.002+25.00%
20min DelayMarket Closed Oct 11 13:15 AET
0Market Cap0.00P/E (Static)
0.010High0.010Low1.50MVolume0.010Open0.008Pre Close15.00KTurnover0.01052wk High0.00%Turnover Ratio0Shares0.00752wk Low--EPS TTM0Float Cap0.010Historical High0.00P/E (Static)0Shs Float0.007Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Actinogen Medical Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||
| Cash income from operating activities | 3.20%4.79M | 223.70%4.64M | -52.62%1.43M | -44.52%3.03M | 5.46M |
| Income from government grants | 3.20%4.79M | 223.70%4.64M | -52.62%1.43M | -44.52%3.03M | --5.46M |
| Cash paid | -60.78%-22.01M | -24.67%-13.69M | -130.66%-10.98M | 43.18%-4.76M | -8.38M |
| Payments to suppliers for goods and services | -25.94%-5.71M | -52.33%-4.54M | -130.73%-2.98M | -12.14%-1.29M | ---1.15M |
| Other cash payments from operating activities | -78.05%-16.3M | -14.38%-9.15M | -130.64%-8M | 51.99%-3.47M | ---7.23M |
| Direct interest paid | -18.27%-20.12K | -59.26%-17.01K | 40.83%-10.68K | 37.49%-18.05K | ---28.88K |
| Direct interest received | -20.63%291.02K | 792.71%366.65K | 51.61%41.07K | -71.20%27.09K | --94.06K |
| Operating cash flow | -94.88%-16.95M | 8.60%-8.7M | -452.07%-9.52M | 39.63%-1.72M | ---2.86M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 77.70%-8.16K | -1,146.14%-36.6K | 52.54%-2.94K | 72.81%-6.19K | -22.76K |
| Net PPE purchase and sale | 77.70%-8.16K | -1,146.14%-36.6K | 52.54%-2.94K | 72.81%-6.19K | ---22.76K |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 77.70%-8.16K | -1,146.14%-36.6K | 52.54%-2.94K | 72.81%-6.19K | ---22.76K |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | 2,076.72%17.95M | -93.36%824.62K | 22.83%12.42M | 3,482.27%10.11M | 282.26K |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | --360K |
| Net common stock issuance | 1,898.03%18.04M | -92.77%902.96K | 22.52%12.49M | --10.2M | ---- |
| Net other financing activities | -17.05%-91.7K | -10.07%-78.34K | 15.38%-71.17K | -8.18%-84.1K | ---77.74K |
| Cash from discontinued financing activities | |||||
| Financing cash flow | 2,076.72%17.95M | -93.36%824.62K | 22.83%12.42M | 3,482.27%10.11M | --282.26K |
| Net cash flow | |||||
| Beginning cash position | -48.32%8.46M | 21.97%16.37M | 166.28%13.42M | -34.00%5.04M | --7.64M |
| Current changes in cash | 112.52%990.66K | -372.77%-7.91M | -65.40%2.9M | 422.83%8.38M | ---2.6M |
| Effect of exchange rate changes | ---- | ---- | --13.39K | ---- | ---- |
| Cash adjustments other than cash changes | ---- | -99.97%10 | --35.27K | ---- | ---- |
| End cash Position | 11.71%9.45M | -48.32%8.46M | 21.97%16.37M | 166.28%13.42M | --5.04M |
| Free cash from | -94.15%-16.96M | 8.25%-8.73M | -450.26%-9.52M | 39.89%-1.73M | ---2.88M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data